The WACC of Vaccibody AS (VACC.OL) is 7.3%.
| Range | Selected | |
| Cost of equity | 6.10% - 8.50% | 7.30% |
| Tax rate | 22.00% - 22.40% | 22.20% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 6.1% - 8.5% | 7.3% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 4.7% | 5.7% |
| Adjusted beta | 0.64 | 0.77 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.10% | 8.50% |
| Tax rate | 22.00% | 22.40% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 6.1% | 8.5% |
| Selected WACC | 7.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for VACC.OL:
cost_of_equity (7.30%) = risk_free_rate (3.35%) + equity_risk_premium (5.20%) * adjusted_beta (0.64) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.